Overview

MLE4901 vs. Placebo for the Treatment of PCOS

Status:
Terminated
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2b double-blind, randomized, parallel-group, placebo-controlled study of MLE4901 versus placebo in women with PCOS.
Phase:
Phase 2
Details
Lead Sponsor:
Millendo Therapeutics US, Inc.
Millendo Therapeutics, Inc.
Collaborators:
Covance
Medpace, Inc.